<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04321642</url>
  </required_header>
  <id_info>
    <org_study_id>071</org_study_id>
    <nct_id>NCT04321642</nct_id>
  </id_info>
  <brief_title>The Effect of Entonox on Stages of Labor in Nulliparous Women</brief_title>
  <official_title>The Effect of Entonox on Stages of Labor in Nulliparous Women :a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajavithi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rajavithi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Trial study about The effect of Entonox associated with duration of labor in Active
      phase and efficacy for relief pain of labor .So investigators start to study up to 14 months
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will enroll participants in 2 groups by randomized . First group will inhale
      Entonox and the second group not receive any gas . The participants in Entonox group will
      inhale gas in 4-5 times for each uterine contraction and Nurse will measure blood pressure ,
      O2 saturation ,pain score before use gas . The outcome,investigators study about Apgar score
      , duration of labor , pain relief in both group,route of delivery and estimated blood loss
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Entonox for duration of labor</measure>
    <time_frame>up to 14 months</time_frame>
    <description>Study about duration of labor after receive Entonox in active phase of labor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of patients who inhaled Entonox for pain relieve</measure>
    <time_frame>up to 14 months</time_frame>
    <description>% of patients relieve pain after inhaled Entonox , Investigators measure by visual analogue scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>ENTONOX</condition>
  <condition>Nulliparous</condition>
  <condition>Duration of Labor</condition>
  <arm_group>
    <arm_group_label>Entonox</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inhalation Entonox in active phase of labor ( cervical dilatation more than 5 cm ) Inhaled Entonox before true uterine contraction in 30 sec , inhaled in 4-5 times for 1 contraction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not receive Entonox</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Not receive any gas when archive in active phase of labor( cervical dilatation more than 5 cm )</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Entonox</intervention_name>
    <description>Entonox gas with mouth piece</description>
    <arm_group_label>Entonox</arm_group_label>
    <other_name>Entonox gas</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Not receive Entonox</intervention_name>
    <description>Not receive any gas</description>
    <arm_group_label>Not receive Entonox</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nulliparity

          -  Age 18 years old or more

          -  Gestational age 37-40+6 wks

          -  Singleton

          -  Cephalic presentation

          -  Cervical dilatation &gt; 5 cm

          -  Estimated fetal weight 2,500-4,000 gm

        Exclusion Criteria:

          -  Estimated fetal weight more than 4,000 gm

          -  High risk pregnancy (Hypertension in pregnancy ,Endocrine disorder , autoimmune
             disorder , epilsepsy etc)

          -  SpO2 &lt; 95 %

          -  Contraindication for Entonox usage ( Severe head injury , asthma , Pulmonary
             disease,Otitis media )

          -  Drug allergy : Metoclopramide , Dimenhydrinate , Pethidine ,Entonox
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Somboon sornsukulrat, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Rajavithi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Siboonluk Lukkhan, MD</last_name>
    <phone>66849945145</phone>
    <email>dr_seraph@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Surasak Chantarasangaram, MD</last_name>
    <phone>66816862194</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rajavithi Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siboonluk Lukkhan, MD</last_name>
      <phone>6649945145</phone>
      <email>dr_seraph@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Surasak Juntharasangaram, MD</last_name>
      <phone>6616862194</phone>
    </contact_backup>
    <investigator>
      <last_name>Siboonluk Lukkhan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>March 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Entonox</keyword>
  <keyword>Nulliiparous</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitrous Oxide</mesh_term>
    <mesh_term>Entonox</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Entonox</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

